Programmed inhibition of an innate immune receptor via de novo designed transmembrane proteins
Colleen A. Maillie, Minghao Zhang, Nadia Gosiet, George Goldenfeld, Gerard J. A. Kroon, Andrew B. Ward, Marco Mravic
This paper designs synthetic proteins that inhibit TLR4 signaling by binding its transmembrane domain, demonstrating the importance of transmembrane interactions in immune signaling.
Proceedings of the National Academy of Sciences · Sep 22, 2026Peer-reviewedBiochemistry